Home › Compare › PVTTF vs DVY

PVTTF vs DVY: Dividend Comparison 2026

PVTTF yields 111111.11% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PVTTF wins by $1.3838190899465547e+27M in total portfolio value
10 years
PVTTF
PVTTF
● Live price
111111.11%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.3838190899465547e+27M
Annual income
$1,381,373,456,343,941,000,000,000,000,000,000.00
Full PVTTF calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — PVTTF vs DVY

📍 PVTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPVTTFDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PVTTF + DVY cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PVTTF pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PVTTF
Annual income on $10K today (after 15% tax)
$9,444,444.44/yr
After 10yr DRIP, annual income (after tax)
$1,174,167,437,892,349,800,000,000,000,000,000.00/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, PVTTF beats the other by $1,174,167,437,892,349,800,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PVTTF + DVY for your $10,000?

PVTTF: 50%DVY: 50%
100% DVY50/50100% PVTTF
Portfolio after 10yr
$6.919095449732774e+26M
Annual income
$690,686,728,171,970,500,000,000,000,000,000.00/yr
Blended yield
99.82%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PVTTF buys
0
DVY buys
0
No recent congressional trades found for PVTTF or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPVTTFDVY
Forward yield111111.11% ✓3.50%
Annual dividend / share$2.00$5.25 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.3838190899465547e+27M$25.1K ✓
Annual income after 10y$1,381,373,456,343,941,000,000,000,000,000,000.00 ✓$437.78
Total dividends collected$1.383658847866035e+27M$4.0K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PVTTF vs DVY ($10,000, DRIP)

YearPVTTF PortfolioPVTTF Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$11,121,811$11,111,111.11$11,050$349.62+$11.11M → PVTTF
2$11,561,029,218$11,549,128,879.66$12,184$361.04+$11561.02M → PVTTF
3$11,232,204,364,934$11,219,834,063,671.13$13,409$372.07+$11232204.35M → PVTTF
4$10,199,601,320,781,262$10,187,582,862,110,782.00$14,730$382.68+$10199601320.77M → PVTTF
5$8,656,721,364,988,387,000$8,645,807,791,575,153,000.00$16,154$392.89+$8656721364988.37M → PVTTF
6$6,867,176,795,058,000,000,000$6,857,914,103,197,462,000,000.00$17,688$402.69+$6867176795058000.00M → PVTTF
7$5,091,669,942,459,710,000,000,000$5,084,322,063,288,997,000,000,000.00$19,338$412.07+$5091669942459709440.00M → PVTTF
8$3,528,599,356,203,225,300,000,000,000$3,523,151,269,364,793,600,000,000,000.00$21,113$421.04+$3.5285993562032256e+21M → PVTTF
9$2,285,638,880,947,370,600,000,000,000,000$2,281,863,279,636,233,000,000,000,000,000.00$23,020$429.61+$2.2856388809473705e+24M → PVTTF
10$1,383,819,089,946,554,900,000,000,000,000,000$1,381,373,456,343,941,000,000,000,000,000,000.00$25,070$437.78+$1.3838190899465547e+27M → PVTTF

PVTTF vs DVY: Complete Analysis 2026

PVTTF — Stock

Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.

Full PVTTF Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this PVTTF vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PVTTF vs SCHDPVTTF vs JEPIPVTTF vs OPVTTF vs KOPVTTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.